Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series

BJU International

Volumn 110, Issue 4, 2012, Pages 517-523

  Nevoux, Pierre ^a   Ouzzane, Adil ^a   Ahmed, Hashim U ^b   Emberton, Mark ^b   Montironi, Rodolfo ^c   Presti Jr , Joseph C ^d   Villers, Arnauld ^a  

^a UNIV LILLE   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

cystoprostatectomy; focal therapy; incidental prostate cancer; morphometry; pathology; prostatic neoplasm

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BILATERAL CANCER; BLADDER CANCER; CANCER GRADING; CANCER MORPHOLOGY; CANCER STAGING; CYSTECTOMY; HUMAN; HUMAN TISSUE; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; QUANTITATIVE ANALYSIS; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CYSTECTOMY; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; TUMOR BURDEN; URINARY BLADDER NEOPLASMS;

EID: 84864430544     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10776.x     Document Type: Article

References (22)

1. Kattan MW,. Comparing prediction tools. Eur Urol 2010; 57: 569-74
2. Wolters T, Montironi R, Mazzucchelli R, et al,. Comparison of incidentally detected prostate cancer with screen-detected prostate cancer treated by prostatectomy. Prostate 2011; [Epub ahead of print]. DOI: 10.1002/pros.21415
3. McNeal JE, Haillot O,. Patterns of spread of adenocarcinoma in the prostate as related to cancer volume. Prostate 2001; 49: 48-57
4. Villers A, McNeal JE, Freiha FS, Stamey TA,. Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors. Cancer 1992; 70: 2313-8
5. Epstein JI, Walsh PC, Carmichael M, Brendler CB,. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994; 271: 368-74 (Pubitemid 24037911)
6. Stamey TA, Freiha FS, McNeal JE, Redwine EA, Whittemore AS, Schmid HP,. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 1993; 71: 933-8 (Pubitemid 23049614)
7. Wolters T, Roobol MJ, Leeuwen PJ, et al,. A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. J Urol 2011; 185: 121-5
8. Kabalin JN, McNeal JE, Price HM, Freiha FS, Stamey TA,. Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations. J Urol 1989; 141: 1091-4 (Pubitemid 19124204)
9. Soos G, Tsakiris I, Szanto J, Turzo C, Haas PG, Dezso B,. The prevalence of prostate carcinoma and its precursor in Hungary: an autopsy study. Eur Urol 2005; 48: 739-44 (Pubitemid 41495371)
10. Haffner J, Potiron E, Bouye S, et al,. Peripheral zone prostate cancers: location and intraprostatic patterns of spread at histopathology. Prostate 2009; 69: 276-82
11. Wise AM, Stamey TA, McNeal JE, Clayton JL,. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 2002; 60: 264-9 (Pubitemid 34831770)
12. Noguchi M, Stamey TA, McNeal JE, Nolley R,. Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers. J Urol 2003; 170: 459-63 (Pubitemid 36870224)
13. Bouye S, Potiron E, Puech P, Leroy X, Lemaitre L, Villers A,. Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology. Prostate 2009; 69: 105-13
14. Trpkov K, Yilmaz A, Bismar TA, Montironi R,. 'Insignificant' prostate cancer on prostatectomy and cystoprostatectomy: variation on a theme 'low-volume/low-grade' prostate cancer? BJU Int 2010; 106: 304-15
15. Mazzucchelli R, Montironi R, Morichetti D, Scarpelli M, Lopez-Beltran A, Cheng L,. Comparison between incidentally and clinically detected prostate cancer: implications for prostate cancer screening programs and focal therapy. Anal Quant Cytol Histol 2010; 32: 151-4
16. Barbisan F, Mazzucchelli R, Scarpelli M, et al,. Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer? BJU Int 2009; 103: 1058-63
17. Montironi R, Cheng L, Mazzucchelli R, et al,. Critical evaluation of the prostate from cystoprostatectomies for bladder cancer: insights from a complete sampling with the whole mount technique. Eur Urol 2009; 55: 1305-9
18. Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA Jr, Shappell SB,. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 2004; 171: 646-51 (Pubitemid 38090448)
19. Ahmed HU, Kirkham A, Arya M, et al,. Is it time to consider a role for MRI before prostate biopsy? Nat Rev Clin Oncol 2009; 6: 197-206
20. Puech P, Potiron E, Lemaitre L, et al,. Dynamic contrast-enhanced- magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens. Urology 2009; 74: 1094-9
21. de la Rosette J, Ahmed H, Barentsz J, et al,. Focal therapy in prostate cancer-report from a consensus panel. J Endourol 2010; 24: 775-80
22. Bott SR, Ahmed HU, Hindley RG, Abdul-Rahman A, Freeman A, Emberton M,. The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer. BJU Int 2010; 106: 1607-11